Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Predictive value of serum-soluble CD154 in fulminant hepatic failure.

Zheng YB, Gao ZL, Zhong F, Huang YS, Peng L, Lin BL, Chong YT.

J Int Med Res. 2008 Jul-Aug;36(4):728-33.

PMID:
18652769
2.

Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury.

Ozawa E, Abiru S, Nagaoka S, Yano K, Komori A, Migita K, Yatsuhashi H, Taura N, Ichikawa T, Ishibashi H, Nakao K.

J Gastroenterol Hepatol. 2011 Aug;26(8):1326-32. doi: 10.1111/j.1440-1746.2011.06743.x.

PMID:
21501222
3.

Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.

Hocher B, Liefeldt L, Quaschning T, Kalk P, Ziebig R, Godes M, Relle K, Asmus G, Stasch JP.

J Am Soc Nephrol. 2007 Apr;18(4):1323-30. Epub 2007 Feb 21.

5.

Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.

Takayama H, Miyake Y, Nouso K, Ikeda F, Shiraha H, Takaki A, Kobashi H, Yamamoto K.

J Gastroenterol Hepatol. 2011 Jan;26(1):116-21. doi: 10.1111/j.1440-1746.2010.06441.x.

6.

Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.

Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM.

Int J Mol Sci. 2015 May 28;16(6):12147-58. doi: 10.3390/ijms160612147.

7.

Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure.

Schmitz V, Dombrowski F, Prieto J, Qian C, Diehl L, Knolle P, Sauerbruch T, Caselmann WH, Spengler U, Leifeld L.

Hepatology. 2006 Aug;44(2):430-9.

PMID:
16871541
8.

Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.

Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M.

J Gastroenterol. 2005 Jan;40(1):52-6.

PMID:
15692789
9.

Serum osteopontin levels in patients with acute liver dysfunction.

Arai M, Yokosuka O, Kanda T, Fukai K, Imazeki F, Muramatsu M, Seki N, Miyazaki M, Ochiai T, Hirasawa H, Saisho H.

Scand J Gastroenterol. 2006 Jan;41(1):102-10.

PMID:
16373283
10.

Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.

Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U.

Am J Pathol. 1999 Jun;154(6):1711-20.

11.

Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.

Young RS, Naseem KM, Pasupathy S, Ahilathirunayagam S, Chaparala RP, Homer-Vanniasinkam S.

Atherosclerosis. 2007 Feb;190(2):452-8. Epub 2006 Jun 13.

PMID:
16777115
12.

Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure.

Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N.

Liver Transpl. 2005 Sep;11(9):1073-9.

13.

Higher serum methionine levels as a predictive factor in patients with irreversible fulminant hepatic failure.

Sato K, Fukushima D, Doi H, Satomi S.

Transplant Proc. 2013 Jun;45(5):1904-6. doi: 10.1016/j.transproceed.2012.11.028.

PMID:
23769068
14.
15.

Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.

Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H.

J Rheumatol. 2001 Dec;28(12):2583-90.

PMID:
11764201
16.

Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure.

Kurokohchi K, Imataki O, Kubo F.

World J Gastroenterol. 2015 Jul 14;21(26):8203-7. doi: 10.3748/wjg.v21.i26.8203.

17.

Hepatitis E virus infection and fulminant hepatic failure during pregnancy.

Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P.

J Gastroenterol Hepatol. 2007 May;22(5):676-82.

PMID:
17444855
18.

[Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A].

Kim JM, Lee YS, Lee JH, Kim W, Lim KS.

Korean J Hepatol. 2008 Dec;14(4):474-82. doi: 10.3350/kjhep.2008.14.4.474. Korean.

19.

Total and biologically active serum-soluble CD154 in patients with chronic idiopathic urticaria.

Garmendia JV, Zabaleta M, Blanca I, Bianco NE, De Sanctis JB.

Allergy Asthma Proc. 2004 Mar-Apr;25(2):121-5.

PMID:
15176497
20.

Early prognostic markers for fatal fulminant hepatic failure cases with viral hepatitis: proton nuclear magnetic resonance spectroscopic studies of serum.

Bala L, Mehrotra M, Mohindra S, Saxena R, Khetrapal CL.

Dig Liver Dis. 2013 Feb;45(2):155-63. doi: 10.1016/j.dld.2012.09.018. Epub 2012 Nov 1.

PMID:
23122710

Supplemental Content

Support Center